Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study. (Q53940587)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

N. Gianotti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M. Setti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P. E. Manconi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F. Leoncini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F. Chiodo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

L. Minoli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M. Moroni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G. Angarano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F. Mazzotta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G. Carosi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G. Antonelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunopathology and Pharmacology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

129-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

A Mutation in Human Immunodeficiency Virus Reverse Transcriptase and Decline in CD4 Lymphocyte Numbers in Long-Term Zidovudine Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Viral resistance patterns selected by antiretroviral drugs and their potential to guide treatment choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

10.1177/039463200201500208

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json